Cargando…

Morbilliform Rash: An Uncommon Herald of SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus first detected in Wuhan, China in 2019 after an outbreak of flu-like illness. The disease came to be known as the coronavirus disease of 2019 (COVID-19). It has spread quickly, spanning many countries, and has become...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Radhika B, Lederman, Yitzchok, Afiari, Agura, Savage, Jacqueline A, Jacob, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444743/
https://www.ncbi.nlm.nih.gov/pubmed/32850199
http://dx.doi.org/10.7759/cureus.9321
_version_ 1783573860850860032
author Kulkarni, Radhika B
Lederman, Yitzchok
Afiari, Agura
Savage, Jacqueline A
Jacob, Jason
author_facet Kulkarni, Radhika B
Lederman, Yitzchok
Afiari, Agura
Savage, Jacqueline A
Jacob, Jason
author_sort Kulkarni, Radhika B
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus first detected in Wuhan, China in 2019 after an outbreak of flu-like illness. The disease came to be known as the coronavirus disease of 2019 (COVID-19). It has spread quickly, spanning many countries, and has become a global pandemic. As this is a novel virus, its varied manifestations and symptomatology are coming to light daily. Although most threatening to the respiratory system, this virus has the propensity to affect multiple organ systems quickly leading to multi-organ dysfunction. Many dermatologic manifestations have been reported with no clear pattern. Most data have been anecdotal.  Here we present a 78-year-old male who tested positive for SARS-CoV-2 with no usual symptoms that would alert one of the possibilities of COVID-19. He did, however, have a diffuse morbilliform rash most notable on the trunk and back. He went on to develop fever thereafter but did not develop any respiratory complications. The rash was short-lived and was treated with topical steroids and oral antihistamines. It is important to know and report new findings of novel diseases not only for diagnosis and treatment but also to place appropriate isolation precautions and containment. Rash may be the initial and sometimes the only manifestation of COVID-19. 
format Online
Article
Text
id pubmed-7444743
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-74447432020-08-25 Morbilliform Rash: An Uncommon Herald of SARS-CoV-2 Kulkarni, Radhika B Lederman, Yitzchok Afiari, Agura Savage, Jacqueline A Jacob, Jason Cureus Dermatology Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus first detected in Wuhan, China in 2019 after an outbreak of flu-like illness. The disease came to be known as the coronavirus disease of 2019 (COVID-19). It has spread quickly, spanning many countries, and has become a global pandemic. As this is a novel virus, its varied manifestations and symptomatology are coming to light daily. Although most threatening to the respiratory system, this virus has the propensity to affect multiple organ systems quickly leading to multi-organ dysfunction. Many dermatologic manifestations have been reported with no clear pattern. Most data have been anecdotal.  Here we present a 78-year-old male who tested positive for SARS-CoV-2 with no usual symptoms that would alert one of the possibilities of COVID-19. He did, however, have a diffuse morbilliform rash most notable on the trunk and back. He went on to develop fever thereafter but did not develop any respiratory complications. The rash was short-lived and was treated with topical steroids and oral antihistamines. It is important to know and report new findings of novel diseases not only for diagnosis and treatment but also to place appropriate isolation precautions and containment. Rash may be the initial and sometimes the only manifestation of COVID-19.  Cureus 2020-07-21 /pmc/articles/PMC7444743/ /pubmed/32850199 http://dx.doi.org/10.7759/cureus.9321 Text en Copyright © 2020, Kulkarni et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Kulkarni, Radhika B
Lederman, Yitzchok
Afiari, Agura
Savage, Jacqueline A
Jacob, Jason
Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
title Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
title_full Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
title_fullStr Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
title_full_unstemmed Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
title_short Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
title_sort morbilliform rash: an uncommon herald of sars-cov-2
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444743/
https://www.ncbi.nlm.nih.gov/pubmed/32850199
http://dx.doi.org/10.7759/cureus.9321
work_keys_str_mv AT kulkarniradhikab morbilliformrashanuncommonheraldofsarscov2
AT ledermanyitzchok morbilliformrashanuncommonheraldofsarscov2
AT afiariagura morbilliformrashanuncommonheraldofsarscov2
AT savagejacquelinea morbilliformrashanuncommonheraldofsarscov2
AT jacobjason morbilliformrashanuncommonheraldofsarscov2